| 0 (0%) | 06-22 04:25 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 30.39 | 1-year : | 35.49 |
| Resists | First : | 26.02 | Second : | 30.39 |
| Pivot price | 25.67 |
|||
| Supports | First : | 25.4 | Second : | 25.02 |
| MAs | MA(5) : | 25.63 |
MA(20) : | 25.56 |
| MA(100) : | 24.67 |
MA(250) : | 23.45 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1  |
| %K %D | K(14,3) : | 60.5 |
D(3) : | 54.7 |
| RSI | RSI(14): 59.9 |
|||
| 52-week | High : | 26.02 | Low : | 20.87 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SFEB ] has closed below upper band by 17.4%. Bollinger Bands are 42.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 25.98 - 26.08 | 26.08 - 26.16 |
| Low: | 25.56 - 25.69 | 25.69 - 25.79 |
| Close: | 25.65 - 25.84 | 25.84 - 25.99 |
Fri, 12 Jun 2026
(SFEB) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Mon, 11 Nov 2024
SFEB Stock Fund Price and Chart — CBOE:SFEB - TradingView
Thu, 23 Feb 2023
Lucas Romano - Wrestling - FloWrestling
Thu, 18 Aug 2022
Discovery of Novel Antibiotics - Novo Nordisk Fonden
Sat, 12 Mar 2022
Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells - PNAS
Mon, 13 Feb 2012
Transplantation of telencephalic neural progenitors induced from embryonic stem cells into subacute phase of focal cerebral ischemia - Nature
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|